Hemispherx Biopharma, Inc. announced the appointment of Ellen Lintal as the company’s new Chief Accounting Officer. She joined the company in 2018 as VP of Finance & Control. Before joining the company, she spent a decade at an international non-profit Organization, serving as Chief Financial Officer and SVP of Finance & Control. Her more than 25-year career also includes public company accounting experience at Corning Inc., Carlisle Companies and AGY, where she led the organizational focus on executing key priorities specializing in financial management, strategic planning and mergers and acquisitions.